Sign in

CIK 0001636651

  • Non-accelerated filer
  • Smaller reporting company

Ovid Therapeutics Inc.

Sign in to watch
Ticker
OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465270895
Phone
+1 212-776-4381
Business address
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-12-08 TAKEDA PHARMACEUTICAL CO LTD 10% owner Conversion +1,250,000 7,000,000
2025-12-08 TAKEDA PHARMACEUTICAL CO LTD 10% owner Conversion · Series A Convertible Preferred Stock −1,250 0
2022-07-01 TAKEDA PHARMACEUTICAL CO LTD 10% owner Other disposition −5,750,000 0
2022-07-01 TAKEDA PHARMACEUTICAL CO LTD 10% owner Other acquisition +5,750,000 5,750,000
2022-07-01 TAKEDA PHARMACEUTICAL CO LTD 10% owner Other disposition · Series A Convertible Preferred Stock −1,250 0
2022-07-01 TAKEDA PHARMACEUTICAL CO LTD 10% owner Other acquisition · Series A Convertible Preferred Stock +1,250 1,250
2019-10-08 TAKEDA PHARMACEUTICAL CO LTD 10% owner Purchase +2,000,000 $2.50 $5.0M 5,750,000

Page 1 of 1 · 7 trades